Research into atherogenesis has been altered radically in the past decade, mainly by the realisation that the macrophage has an important (maybe central) role in this disease and that low density lipoprotein (LDL) itself may not be atherogenic but rather LDL modified by oxidation (and perhaps other mechanisms)
About a decade ago in Steinberg's laboratory in San Diego LDL was first shown to be taken up much faster by macrophages after it had been incubated with arterial endothelial cells in culture.' This effect was later shown to be due to the oxidation of the LDL by the endothelial cells.2 Oxidised LDL (but not normal LDL) is recognised by a receptor (or possibly a family of receptors) on macrophages known as the scavenger receptor, which has now been cloned. 3 Oxidised LDL is then rapidly endocytosed by the macrophages, delivered to the lysosomes, and degraded. The cholesterol accumulates within the macrophage, mainly as cholesteryl esters.
Scavenger receptors are also found on endothelial cells,4 but only in low numbers, and on arterial smooth muscle cells, but only after stimulation by phorbol esters or platelet products.5
Sequence of events We can therefore envisage a scenario in which plasma LDL enters the arterial wall from the luminal surface and is locally oxidised within the intima of the artery. All four major cell types within atherosclerotic lesions (endothelial cells, smooth muscle cells, macrophages, and lymphocytes) can oxidise LDL'16-9 but the macrophage seems to be the most active. The oxidised LDL may then be internalised rapidly by macrophages, converting them into cholesterol-laden foam cells. Many of the foam cells in human atherosclerotic lesions are now known to be derived from macrophages.'0 LDL oxidation is believed to occur locally within atherosclerotic lesions rather than within the general circulation, because even a few per cent of serum will completely inhibit oxidation of LDL.8
LDL oxidation by cells is believed to be caused by free radicals, substances with unpaired electrons which tend to be highly reactive. The nature of these free radicals and their sources within the cells are still highly controversial, because free radical chemistry is difficult to study. We still do not know whether cells oxidise LDL by releasing simple oxidising agents (such as superoxide (02) or hydrogen peroxide) which then attack LDL or by releasing lipid peroxidation products, formed by the oxidation of the cells' own lipids. These lipid peroxidation products may then become incorporated into the LDL particles and initiate the oxidation of the LDL's own lipids.
Whatever the mechanism, the polyunsaturated fatty acids in LDL become oxidised and converted into lipid hydroperoxides. These fragment into aldehydes, which are believed to combine covalently with lysine and maybe other amino acids in apolipoprotein B-100, the protein moiety of LDL." 12 The modified apolipoprotein B-100 then becomes recognised by the scavenger receptors of macrophages.
The evidence that this is what happens in atherosclerotic lesions in vivo is accumulating rapidly. LDL gently extracted from human or animal lesions was shown to be oxidised and was taken up faster by macrophages by their scavenger receptors." Also antibodies against oxidised LDL stained lesions but not the normal arterial wall. '4 In addition, lipid-soluble antioxidants that inhibited LDL oxidation in vitro protected against atherosclerosis in laboratory animals. Probucol protected against lesion development in mostl5 16 but not all studies'7 in rabbits, butylated hydroxytoluene protected in rabbits,'8 and vitamin E protected in primates.'9 Evidence about the effects of vitamin E in rabbits was conflicting and difficult to interpret.) Definitive proof that oxidised LDL is causally related to atherogenesis in humans, however, is still awaited.
As well as converting macrophages into cholesterolladen foam cells, oxidised LDL may be involved in atherogenesis in several other ways (reviewed by Steinberg et al"). It is directly chemotactic for monocytes and once they have entered the arterial wall and differentiated into macrophages it may inhibit their motility, trapping them within the wall. Oxidised LDL is cytotoxic, because of the lipid peroxidation products it contains, and this may explain some of the damage that occurs to the endothelium and macrophages in the more advanced lesions. It also inhibits the generation or effects or both of endothelium derived relaxing factor (nitric oxide) in arteries and therefore could contribute to vasospasm in diseased vessels.
There has recently been much interest in the effects of mildly oxidised LDL (or minimally modified LDL), which has effects that are very different from those of the highly oxidised LDL studied previously. Thus mildly oxidised LDL (but not highly oxidised LDL) increases Vitamin E seems to be the single most important antioxidant in LDL and when vitamin E is taken by mouth its concentration in LDL increases 2-4 fold. After isolation this vitamin E enriched LDL was less susceptible to oxidation in in vitro test systems, including oxidation by macrophages.25-2' LDL is golden yellow because it contains the antioxidant ,B carotene. The fi carotene content of LDL was greatly increased when subjects were given fi carotene by mouth, but the LDL did not seem to be any less susceptible to oxidation after isolation.27
There is epidemiological evidence that high vitamin E or,B carotene intake is associated with a low rate of coronary heart disease. Gey et al found that mortality from coronary heart disease was strongly inversely related to dietary vitamin E when they compared several different European populations.28 Though fi carotene does not apparently render LDL less susceptible to oxidation, its intake was also inversely correlated with coronary heart disease but less strongly so. In a Scottish study, the risk of angina was inversely and independently related to the plasma concentration of vitamin E.29 In a very large study of nurses in the United States the risk of coronary heart disease was 30-40% less in those with a high intake of vitamin E or ,B carotene and a prospective study of elderly people also in the United States, showed independent inverse relation betweenf, carotene intake and cardiovascular mortality. 
